Closed
SectorHealthcare
9.03 -2.48
24h
Min
9
Max
9.34
Income | 9.3M -85M |
---|---|
Sales | 12M 20M |
EPS | -0.985 |
Profit margin | -423.341 |
Employees | 270 |
EBITDA | 5.6M -84M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +256.34% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -366M 816M |
---|---|
Previous open | 11.51 |
Previous close | 9.03 |
By Acuity
39%
61%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 33.14 USD 256.34%
High 45 USD
Low 17 USD
Based on 8 Wall Street analysts offering 12 month price targets forSyndax Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$